{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T07:48:03Z","timestamp":1793778483679,"version":"4.6.1"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T00:00:00Z","timestamp":1611532800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-17-2-0055"],"award-info":[{"award-number":["W81XWH-17-2-0055"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-15-1-0096"],"award-info":[{"award-number":["W81XWH-15-1-0096"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01 EY017427"],"award-info":[{"award-number":["R01 EY017427"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["U24 EY029903"],"award-info":[{"award-number":["U24 EY029903"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["U24 EY029893"],"award-info":[{"award-number":["U24 EY029893"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01 EY022349"],"award-info":[{"award-number":["R01 EY022349"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.redox.2021.101883","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T01:36:53Z","timestamp":1611884213000},"page":"101883","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Retinal oxidative stress activates the NRF2\/ARE pathway: An early endogenous protective response to ocular hypertension"],"prefix":"10.1016","volume":"42","author":[{"given":"Sarah","family":"Naguib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon R.","family":"Backstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Calkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2566-8723","authenticated-orcid":false,"given":"Tonia S.","family":"Rex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.redox.2021.101883_bib1","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1167\/iovs.17-21850","article-title":"Sodium iodate produces a strain-dependent retinal oxidative stress response measured in vivo using QUEST MRI","volume":"58","author":"Berkowitz","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"11","key":"10.1016\/j.redox.2021.101883_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-018-1061-4","article-title":"Antioxidants prevent inflammation and preserve the optic projection and visual function in experimental neurotrauma","volume":"9","author":"Bernardo-Colon","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.redox.2021.101883_bib3","doi-asserted-by":"crossref","DOI":"10.1023\/A:1006002419244","article-title":"The molecular basis of the hypoxia response pathway: tumour hypoxia as a therapy target","author":"Blancher","year":"1998","journal-title":"Canc. Metastasis Rev."},{"key":"10.1016\/j.redox.2021.101883_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/mt.2015.198","article-title":"Virus-mediated EpoR76E therapy slows optic nerve axonopathy in experimental glaucoma","author":"Bond","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.redox.2021.101883_bib5","series-title":"Biochemical Pharmacology","article-title":"The Nrf2 cell defence pathway: keap1-dependent and -independent mechanisms of regulation","author":"Bryan","year":"2013"},{"key":"10.1016\/j.redox.2021.101883_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2012.07.001","article-title":"Critical pathogenic events underlying progression of neurodegeneration in glaucoma","author":"Calkins","year":"2012","journal-title":"Prog. Retin. Eye Res."},{"issue":"5","key":"10.1016\/j.redox.2021.101883_bib7","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1167\/iovs.12-9483i","article-title":"The cell and molecular biology of glaucoma: axonopathy and the brain","volume":"53","author":"Calkins","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.redox.2021.101883_bib8","doi-asserted-by":"crossref","DOI":"10.1089\/ars.2008.2242","article-title":"The Nrf2\/ARE pathway as a potential therapeutic target in neurodegenerative disease","author":"Calkins","year":"2009","journal-title":"Antioxidants Redox Signal."},{"issue":"1","key":"10.1016\/j.redox.2021.101883_bib9","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0169-328X(99)00032-7","article-title":"Caspase inhibitors block the retinal ganglion cell death following optic nerve transection","volume":"67","author":"Chaudhary","year":"1999","journal-title":"Mol. Brain Res."},{"issue":"7","key":"10.1016\/j.redox.2021.101883_bib10","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.1167\/iovs.13-12415","article-title":"The photopic negative response of the mouse electroretinogram: reduction by acute elevation of intraocular pressure","volume":"54","author":"Chrysostomou","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.redox.2021.101883_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.coph.2012.09.008","article-title":"Oxidative stress and mitochondrial dysfunction in glaucoma","author":"Chrysostomou","year":"2013","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.redox.2021.101883_bib13","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.15239.1","article-title":"GSK-3\u03b2, a double-edged sword in Nrf2 regulation: Implications for neurological dysfunction and disease","author":"Culbreth","year":"2018","journal-title":"F1000Research"},{"key":"10.1016\/j.redox.2021.101883_bib14","doi-asserted-by":"crossref","DOI":"10.3109\/10409238.2013.838205","article-title":"Transcriptional regulation by hypoxia inducible factors","author":"Dengler","year":"2014","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.redox.2021.101883_bib15","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/eye.2016.94","article-title":"Revisiting the role of erythropoietin for treatment of ocular disorders","volume":"30","author":"Ding","year":"2016","journal-title":"Nat. Eye"},{"issue":"19","key":"10.1016\/j.redox.2021.101883_bib16","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1111\/febs.14379","article-title":"The role of Nrf2 signaling in counteracting neurodegenerative diseases","volume":"285","author":"Dinkova-Kostova","year":"2018","journal-title":"FEBS J."},{"issue":"3","key":"10.1016\/j.redox.2021.101883_bib17","first-page":"459","article-title":"Photopic negative response in diagnosis of glaucoma: an experimental study in glaucomatous rabbit model","volume":"8","author":"Elgohary","year":"2015","journal-title":"Int. J. Ophthalmol."},{"issue":"6","key":"10.1016\/j.redox.2021.101883_bib18","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.exer.2010.03.002","article-title":"PI3K\/Akt and mTOR\/p70S6K pathways mediate neuroprotectin D1-induced retinal pigment epithelial cell survival during oxidative stress-induced apoptosis","volume":"90","author":"Faghiri","year":"2010","journal-title":"Exp. Eye Res."},{"issue":"9","key":"10.1016\/j.redox.2021.101883_bib19","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1167\/iovs.09-5044","article-title":"Time course changes of oxidative stress markers in a rat experimental glaucoma model","volume":"51","author":"Ferreira","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.redox.2021.101883_bib20","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.omtm.2017.04.003","article-title":"Spatially and temporally regulated NRF2 gene therapy using Mcp-1 promoter in retinal ganglion cell injury","volume":"5","author":"Fujita","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"2 SUPPL. 1","key":"10.1016\/j.redox.2021.101883_bib21","article-title":"Relationship between intraocular pressure and preservation of visual field in glaucoma","volume":"48","author":"Goldberg","year":"2003","journal-title":"Surv. Ophthalmol."},{"issue":"5","key":"10.1016\/j.redox.2021.101883_bib22","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/jnc.12325","article-title":"Critical role of Nrf2 in oxidative stress-induced retinal ganglion cell death","volume":"127","author":"Himori","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.redox.2021.101883_bib23","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-016-0499-5","article-title":"Virus-mediated EpoR76E gene therapy preserves vision in a glaucoma model by modulating neuroinflammation and decreasing oxidative stress","author":"Hines-Beard","year":"2016","journal-title":"J. Neuroinflammation"},{"issue":"9","key":"10.1016\/j.redox.2021.101883_bib24","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1167\/iovs.06-0606","article-title":"Hsp27 phosphorylation in experimental glaucoma","volume":"48","author":"Huang","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.redox.2021.101883_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2015.08.001","article-title":"The complexity of the Nrf2 pathway: beyond the antioxidant response","author":"Huang","year":"2015","journal-title":"JNB (J. Nutr. Biochem.)"},{"issue":"6","key":"10.1016\/j.redox.2021.101883_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065389","article-title":"\u03b1-Lipoic acid antioxidant treatment limits glaucoma-related retinal ganglion cell death and dysfunction","volume":"8","author":"Inman","year":"2013","journal-title":"PloS One"},{"issue":"2424","key":"10.1016\/j.redox.2021.101883_bib27","article-title":"The role of Nrf2 transcription factor in ganglion cell survival in glaucoma","volume":"55","author":"Inman","year":"2014","journal-title":"IOVS (Investig. Ophthalmol. Vis. Sci.)"},{"issue":"1\u20132","key":"10.1016\/j.redox.2021.101883_bib28","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.brainres.2004.06.077","article-title":"Akt is activated via insulin\/IGF-1 receptor in rat retina with episcleral vein cauterization","volume":"1022","author":"Kanamori","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.redox.2021.101883_bib29","series-title":"Normal Tension Glaucoma: Review of Current Understanding and Mechanisms of the Pathogenesis","author":"Killer","year":"2018"},{"key":"10.1016\/j.redox.2021.101883_bib30","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.neulet.2014.12.054","article-title":"Valproic acid prevents retinal degeneration in a murine model of normal tension glaucoma","volume":"588","author":"Kimura","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.redox.2021.101883_bib31","series-title":"Targeting Oxidative Stress for Treatment of Glaucoma and Optic Neuritis","author":"Kimura","year":"2017"},{"issue":"3","key":"10.1016\/j.redox.2021.101883_bib32","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.freeradbiomed.2005.03.025","article-title":"Dynamic changes in reactive oxygen species and antioxidant levels in retinas in experimental glaucoma","volume":"39","author":"Ko","year":"2005","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.redox.2021.101883_bib33","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1471-4159.2010.06903.x","article-title":"Long-acting genipin derivative protects retinal ganglion cells from oxidative stress models in vitro and in vivo through the Nrf2\/antioxidant response element signaling pathway","volume":"115","author":"Koriyama","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.redox.2021.101883_bib34","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.brainres.2012.12.041","article-title":"Protective effect of lipoic acid against oxidative stress is mediated by Keap1\/Nrf2-dependent heme oxygenase-1 induction in the RGC-5 cellline","volume":"1499","author":"Koriyama","year":"2013","journal-title":"Brain Res."},{"key":"10.1016\/j.redox.2021.101883_bib35","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.redox.2018.08.014","article-title":"Identification of a functional antioxidant response element at the HIF1A locus","volume":"19","author":"Lacher","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2021.101883_bib36","author":"Levin"},{"key":"10.1016\/j.redox.2021.101883_bib37","doi-asserted-by":"crossref","DOI":"10.7150\/ijbs.25996","article-title":"The Nrf2 signaling in retinal ganglion cells under oxidative stress in ocular neurodegenerative diseases","author":"Liu","year":"2018","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.redox.2021.101883_bib38","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/397178","article-title":"Clinical applications of the photopic negative response to optic nerve and retinal diseases","author":"Machida","year":"2012","journal-title":"J. Ophthalmol."},{"issue":"6","key":"10.1016\/j.redox.2021.101883_bib39","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.freeradbiomed.2004.06.001","article-title":"Retinal oxidative stress induced by high intraocular pressure","volume":"37","author":"Moreno","year":"2004","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2021.101883_bib40","doi-asserted-by":"crossref","DOI":"10.1111\/j.1442-9071.2012.02789.x","article-title":"Retina ganglion cell degeneration in glaucoma: an opportunity missed? A review","author":"Morgan","year":"2012","journal-title":"Clin. Exp. Ophthalmol."},{"issue":"6","key":"10.1016\/j.redox.2021.101883_bib41","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1167\/iovs.18-25272","article-title":"The relationship between the photopic negative response and retinal ganglion cell topography","volume":"60","author":"Morny","year":"2019","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.redox.2021.101883_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104695","article-title":"Galantamine protects against synaptic, axonal, and vision deficits in experimental neurotrauma","volume":"134","author":"Naguib","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.redox.2021.101883_bib43","article-title":"Intravitreal injection worsens outcomes in a mouse model of indirect traumatic optic neuropathy from closed globe injury","author":"Naguib","year":"2020","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.redox.2021.101883_bib44","series-title":"Nrf2 Is an Attractive Therapeutic Target for Retinal Diseases","author":"Nakagami","year":"2016"},{"issue":"20","key":"10.1016\/j.redox.2021.101883_bib45","doi-asserted-by":"crossref","first-page":"15466","DOI":"10.1074\/jbc.M000361200","article-title":"Transcriptional regulation of the antioxidant response element. Activation by Nrf2 and repression by MafK","volume":"275","author":"Nguyen","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2021.101883_bib46","series-title":"The Nrf2-Antioxidant Response Element Signaling Pathway and its Activation by Oxidative Stress * ARE-Mediated Pathway","author":"Nguyen","year":"2009"},{"key":"10.1016\/j.redox.2021.101883_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.freeradbiomed.2013.02.008","article-title":"Regulation of Nrf2 - an update","author":"Niture","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2021.101883_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.coph.2012.09.002","article-title":"Maintenance of retinal ganglion cell mitochondrial functions as a neuroprotective strategy in glaucoma","author":"Osborne","year":"2013","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.redox.2021.101883_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.niox.2018.11.002","article-title":"Inhibition of JNK and activation of the AMPK-Nrf2 axis by corosolic acid suppress osteolysis and oxidative stress","author":"Peng","year":"2019","journal-title":"Nitric Oxide Biol. Chem."},{"key":"10.1016\/j.redox.2021.101883_bib50","article-title":"Electrophysiological assessment of retinal ganglion cell function","author":"Porciatti","year":"2014","journal-title":"Exp. Eye Res."},{"issue":"2","key":"10.1016\/j.redox.2021.101883_bib51","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1167\/iovs.12-11201","article-title":"Photopic negative response versus pattern electroretinogram in early glaucoma","volume":"54","author":"Preiser","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"10","key":"10.1016\/j.redox.2021.101883_bib52","doi-asserted-by":"crossref","first-page":"5862","DOI":"10.1167\/iovs.15-16810","article-title":"In vivo imaging of retinal oxidative stress using a reactive oxygen species-activated fluorescent probe","volume":"56","author":"Prunty","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.redox.2021.101883_bib53","author":"Rasband"},{"key":"10.1016\/j.redox.2021.101883_bib54","doi-asserted-by":"crossref","DOI":"10.1159\/000488970","article-title":"Functional and structural effects of erythropoietin subconjunctival administration in glaucomatous animals","volume":"3","author":"Resende","year":"2018","journal-title":"Biomed. Hub"},{"issue":"10","key":"10.1016\/j.redox.2021.101883_bib55","doi-asserted-by":"crossref","first-page":"E2393","DOI":"10.1073\/pnas.1714888115","article-title":"Axogenic mechanism enhances retinal ganglion cell excitability during early progression in glaucoma","volume":"115","author":"Risner","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"1","key":"10.1016\/j.redox.2021.101883_bib56","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1158\/2159-8290.CD-16-0512","article-title":"A first-in-human phase I study of the ATP-competitive AKT inhibitor Ipatasertib demonstrates Robust and safe targeting of AKT in patients with solid tumors","volume":"7","author":"Saura","year":"2017","journal-title":"Canc. Discov."},{"issue":"1","key":"10.1016\/j.redox.2021.101883_bib57","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-2141.2006.06252.x","article-title":"PI3K\/Akt-dependent Epo-induced signalling and target genes in human early erythroid progenitor cells","volume":"135","author":"Sivertsen","year":"2006","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.redox.2021.101883_bib58","doi-asserted-by":"crossref","DOI":"10.1089\/hum.2011.052","article-title":"Systemic adeno-associated virus-mediated gene therapy preserves retinal ganglion cells and visual function in DBA\/2J glaucomatous mice","author":"Sullivan","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.redox.2021.101883_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2006.07.003","article-title":"Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences","author":"Tezel","year":"2006","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.redox.2021.101883_bib60","doi-asserted-by":"crossref","DOI":"10.1089\/ars.2017.7342","article-title":"Transcriptional regulation by Nrf2","author":"Tonelli","year":"2018","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.redox.2021.101883_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/antiox6020027","article-title":"Strange bedfellows: nuclear factor, erythroid 2-Like 2 (Nrf2) and hypoxia-inducible factor 1 (HIF-1) in tumor hypoxia","author":"Toth","year":"2017","journal-title":"Antioxidants"},{"key":"10.1016\/j.redox.2021.101883_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2012.03.005","article-title":"The Nrf2-antioxidant response element pathway: a target for regulating energy metabolism","author":"Vomhof-DeKrey","year":"2012","journal-title":"JNB (J. Nutr. Biochem.)"},{"key":"10.1016\/j.redox.2021.101883_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2014.12.013","article-title":"The Keap1-Nrf2-antioxidant response element pathway: a review of its regulation by melatonin and the proteasome","author":"Vriend","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.redox.2021.101883_bib64","doi-asserted-by":"crossref","DOI":"10.1167\/iovs.07-1099","article-title":"Essential roles of the PI3 kinase\/Akt pathway in regulating Nrf2-dependent antioxidant functions in the RPE","author":"Wang","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.redox.2021.101883_bib65","article-title":"The potential role of nuclear factor erythroid 2-related factor 2 (Nrf2) in glaucoma: a review","author":"Wang","year":"2020","journal-title":"Med. Sci. Mon. Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.redox.2021.101883_bib66","series-title":"Activation of Nrf2\/HO-1 Pathway Protects Retinal Ganglion Cells from a Rat Chronic Ocular Hypertension Model of Glaucoma","author":"Wang Zhi-lan Yuan","year":"2019"},{"key":"10.1016\/j.redox.2021.101883_bib67","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: a review","author":"Weinreb","year":"2014","journal-title":"JAMA, J. Am. Med. Assoc."},{"issue":"4","key":"10.1016\/j.redox.2021.101883_bib68","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1128\/MCB.16.4.1722","article-title":"Wortmannin inactivates phosphoinositide 3-kinase by covalent modification of Lys-802, a residue involved in the phosphate transfer reaction","volume":"16","author":"Wymann","year":"1996","journal-title":"Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.redox.2021.101883_bib69","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/jnc.13064","article-title":"Neuroprotective role of Nrf2 for retinal ganglion cells in ischemia-reperfusion","volume":"133","author":"Xu","year":"2015","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.redox.2021.101883_bib70","doi-asserted-by":"crossref","DOI":"10.1167\/iovs.16-19153","article-title":"Antioxidant treatment limits neuroinflammation in experimental glaucoma","volume":"57","author":"Yang","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.redox.2021.101883_bib71","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2016.2714","article-title":"Oxidative stress in the trabecular meshwork (Review)","author":"Zhao","year":"2016","journal-title":"Int. J. Mol. Med."},{"issue":"4","key":"10.1016\/j.redox.2021.101883_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019456","article-title":"Age-related retinopathy in NRF2-deficient mice","volume":"6","author":"Zhao","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.redox.2021.101883_bib73","first-page":"1212","volume":"vol. 48","author":"Zhong","year":"2007"},{"issue":"1","key":"10.1016\/j.redox.2021.101883_bib74","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1167\/iovs.09-3947","article-title":"The microbead occlusion model: a paradigm for induced ocular hypertension in rats and mice","volume":"51","author":"Sappington","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.redox.2021.101883_bib75","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1523\/JNEUROSCI.4089-13.2014","article-title":"Absence of transient receptor potential vanilloid-1 accelerates stress-induced axonopathy in the optic projection","volume":"34","author":"Ward","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.redox.2021.101883_bib76","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.freeradbiomed.2018.01.013","article-title":"Nrf2\/ARE pathway attenuates oxidative and apoptotic response in human osteoarthritis chondrocytes by activating ERK1\/2\/ELK1-P70S6K-P90RSK signaling axis","volume":"116","author":"Khan","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2021.101883_bib77","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.redox.2018.05.002","article-title":"Antioxidant response elements: Discovery, classes, regulation and potential applications","volume":"17","author":"Raghunath","year":"2018","journal-title":"Redox Biol."},{"issue":"3","key":"10.1016\/j.redox.2021.101883_bib78","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10059-009-0050-y","article-title":"Transcriptional regulation of the AP-1 and Nrf2 target gene sulfiredoxin","volume":"27","author":"Soriano","year":"2009","journal-title":"Mol. Cells"}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231721000318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231721000318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:58:25Z","timestamp":1778853505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231721000318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":77,"alternative-id":["S2213231721000318"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2021.101883","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retinal oxidative stress activates the NRF2\/ARE pathway: An early endogenous protective response to ocular hypertension","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2021.101883","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101883"}}